Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
about
A systematic review of patients with Merkel cell carcinoma of the head and neck and a negative sentinel lymph node biopsyPrognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studiesMerkel cell carcinoma of the eyelid and periocular region.Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.Merkel cell carcinoma: a retrospective study on 48 cases and review of literatureMerkel cell carcinoma of the head and neck: a single institutional experience.A practical update of surgical management of merkel cell carcinoma of the skinSentinel lymph node biopsy in nonmelanoma skin cancer patients.Radiation therapy in the management of Merkel cell carcinoma: current perspectivesBoth tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinomaClinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.Shared decision-making in treatment of Merkel cell carcinoma.Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.Natural history of merkel cell carcinoma following locoregional recurrence.Merkel cell carcinoma: 30-year experience from a single institution.A review of radiotherapy for merkel cell carcinoma of the head and neck.Positive sentinel lymph node biopsy predicts local metastases during the course of disease in Merkel cell carcinoma.Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinomaMolecular imaging and therapy of merkel cell carcinoma.Sentinel lymph node biopsy for cutaneous head and neck malignancies.Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists.Merkel cell carcinoma of the head and neck: poorer prognosis than non-head and neck sites.Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neckUnderstanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study.Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report.Role of sentinel lymph node biopsy in the management of merkel cell carcinoma.Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.Sentinel lymph node in Merkel cell carcinoma: to biopsy or not to biopsy?Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience.Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma.Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival.An ultrasonography-cytology protocol for the diagnostic management of regional nodes in a subset of patients with Merkel cell carcinoma of the skin.Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy.Merkel Cell Carcinoma.Prognostic factors and immunobiologic insights into Merkel cell carcinoma.Lack of clinical impact of 18 F-fluorodeoxyglucose positron emission tomography with simultaneous computed tomography for stage I and II Merkel cell carcinoma with concurrent sentinel lymph node biopsy staging: A single institutional experience from
P2860
Q33640268-03107773-B7CD-4EE1-A17B-0849CFC1541DQ33757633-2E0DDBAB-E4E6-4A1A-AADE-EC3BC805CAE3Q33820311-B4BA41FA-1499-44AE-9424-5C43627792EBQ34076523-EA0ACC02-9D56-41CC-B2F5-C61CAA3BD8A9Q34241274-43AF5668-3BA2-4D2E-85AF-59C03B4E47BEQ36253599-9AAB5E50-8E92-4FBC-A838-5FF578776B31Q36567288-28321AB0-B2AB-457F-9E0E-7438E3113F9BQ36605948-21B749DE-F9D6-4166-97C8-2779559FE947Q36651335-F91B8B80-4E66-4A66-821D-C262965DEC6AQ36737883-006F8C3A-BD10-4F80-9226-539F26B1D697Q36997169-069DB9A8-2B0E-4A8C-B5DB-BD504211D06AQ37261676-CC33AD0D-5B61-468D-9C20-838C11DDE85FQ37337074-69F458BD-04B7-44A3-9356-DF494C0A8655Q37647879-9A6A50E3-38CC-4639-AD82-0995BD719009Q37656777-ACFD441A-19AD-441E-9609-8E4DEDD7880DQ37954587-27D67AD3-C0EC-4B64-9351-3FD1C98D949CQ37997576-91869644-7872-4905-A3D8-338AE6238040Q38064764-837F5EEA-0618-44E1-B699-CC390E086575Q38065149-D273AE0D-C678-46AD-BA9A-F776D78A7A8FQ38080908-464E26F8-8D90-48F9-A90E-79090F12FA3CQ38084205-B5646754-9CF3-4EBE-84FD-B6FE3CC84E85Q38208416-B56E51A4-3296-45AA-9F85-0ABC7516BFC8Q38286125-FC877BE2-4357-4E39-BE97-7C4664787D84Q38610915-751604C4-A145-47DF-9B31-3EFD4F3D30D4Q39012295-E4E24D28-C77D-47DF-BF7D-65BCCA291DF2Q40910748-739E630C-B0D3-4B4C-A247-A286D2783A00Q41039736-A9BCE1D5-F350-4A72-91A8-C804DCC5B3CCQ41667462-6FBA7D40-1DD6-42E3-AAD7-E06C60093284Q41695830-62A47E8D-C73B-4240-BA24-94E6957416C9Q42429509-48181E1F-D36E-4B4A-974E-FEFA2950AF20Q43427630-0F65B9C1-E6F5-45B8-A11C-E2FAC19AA6A2Q43497944-7EEDB718-BD71-473C-93A9-350E5C66C734Q43751746-5396EFF6-5C70-46DF-9F22-78542802B328Q44590585-8FB2B201-8279-45F0-B7CB-4D6FC570C1B7Q45824530-2E69EB33-E8BC-47A1-8A0D-C792F9BC540FQ46897043-E7DD7C8A-CD21-45FE-93BE-7EA05202C045Q51012152-E1D8CFBF-11C7-4BDA-ADBE-D277808E0A4FQ51017171-185894DB-D341-48FE-886D-67756E7A5EA1Q52939164-BE5140FF-A026-422F-97F3-F8DDBA70C637Q52990328-7B077521-621D-45F9-B4AB-1D7AFEA2AED6
P2860
Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recurrence and survival in pat ...... nts from a single institution.
@ast
Recurrence and survival in pat ...... nts from a single institution.
@en
type
label
Recurrence and survival in pat ...... nts from a single institution.
@ast
Recurrence and survival in pat ...... nts from a single institution.
@en
prefLabel
Recurrence and survival in pat ...... nts from a single institution.
@ast
Recurrence and survival in pat ...... nts from a single institution.
@en
P2093
P2860
P1476
Recurrence and survival in pat ...... nts from a single institution.
@en
P2093
Daniel G Coit
Dennis H Kraus
Joanne F Chou
Katherine S Panageas
Klaus J Busam
Mary S Brady
Melissa P Pulitzer
Ryan C Fields
P2860
P2888
P304
P356
10.1245/S10434-011-1662-Y
P577
2011-03-24T00:00:00Z
P6179
1008688629